Search Results - "Abt, Peter L."

Donor Warm Ischemia Time in DCD Liver Transplantation—Working Group Report From the ILTS DCD, Liver Preservation, and Machine Perfusion Consensus Conference by Kalisvaart, Marit, Croome, Kristopher P., Hernandez-Alejandro, Roberto, Pirenne, Jacques, Cortés-Cerisuelo, Miriam, Miñambres, Eduardo, Abt, Peter L.

“…Donation after circulatory death (DCD) grafts are commonly used in liver transplantation. Attributable to the additional ischemic event during the donor warm…”
Get full text

Impact of Advanced Renal Dysfunction on Posttransplant Outcomes After Living Donor Liver Transplantation in the United States by Bittermann, Therese, Abt, Peter L., Olthoff, Kim M., Kaur, Navpreet, Heimbach, Julie K., Emamaullee, Juliet

“…Survival after living donor liver transplantation (LDLT) in the United States is excellent. However, the significance of pretransplant kidney disease on…”
Get full text

Kidney transplantation and donation in the transgender population: A single‐institution case series by Ramadan, Omar I., Naji, Ali, Levine, Matthew H., Porrett, Paige M., Dunn, Ty B., Nazarian, Susanna M., Weinrieb, Robert M., Kaminski, Mary, Johnson, David, Trofe‐Clark, Jennifer, Lorincz, Ilona S., Blumberg, Emily A., Weikert, Blair C., Bleicher, Melissa, Abt, Peter L.

“…The medical needs of the transgender population are increasingly recognized within the US health care system. Hormone therapy and gender‐affirming surgery…”
Get full text

Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States by Sawinski, Deirdre, Goldberg, David S., Blumberg, Emily, Abt, Peter L., Bloom, Roy D., Forde, Kimberly A.

“…Background. The effectiveness of liver transplant (LT) in human immunodeficiency virus (HIV) and HIV/hepatitis C virus (HCV) coinfected recipients in the…”
Get full text

The Association Between the Origin of the Donation After Circulatory Death Liver Recovery Team and Graft Survival: A National Study by Ibeabuchi, Tobenna, Li, Eric, Cywes, Claire, Bittermann, Therese, Mahmud, Nadim, Abt, Peter L

“…Transplant centers have traditionally relied upon procurement teams from their own programs (transplant program procurement team [TPT]) to recover donation…”
Get full text

Survival following liver transplantation from non-heart-beating donors by ABT, Peter L, DESAI, Niraj M, CRAWFORD, Michael D, FORMAN, Lisa M, MARKMANN, Joseph W, OLTHOFF, Kim M, MARKMANN, James F

“…To determine whether patient and graft survival following transplantation with non-heart-beating donor (NHBD) hepatic allografts is equivalent to…”
Get full text

MELD‐based allocation at 20: Can we evolve and mature? by Bittermann, Therese, Abt, Peter L.

“…The authors comment on a novel method to estimate mortality on the liver transplant waitlist using joint models as described by Goudsmit et al. (page…”
Get full text

Transplanting Hepatitis C–Positive Kidneys by Reese, Peter P, Abt, Peter L, Blumberg, Emily A, Goldberg, David S

“…New antiviral therapies for hepatitis C virus infection, with cure rates exceeding 95%, should prompt transplant-community leaders to view HCV-positive organs…”
Get full text

Reply: How does ex vivo liver perfusion help improve the outcomes of liver transplantation in donation after cardiac death (DCD) donors? by Ibeabuchi, Tobenna, Li, Eric, Bittermann, Therese, Mahmud, Nadim, Abt, Peter L

Get full text

Can ex-situ normothermic perfusion improve graft survival compared to static cold storage among donation after circulatory death liver allografts? by Ibeabuchi, Tobenna, Li, Eric, Bittermann, Therese, Mahmud, Nadim, Abt, Peter L

“…Limited data suggest that ex-situ normothermic liver perfusion (ENLP) may improve the outcomes of donation after circulatory death (DCD) liver transplants…”
Get full text

Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients by Goldberg, David S, Abt, Peter L, Blumberg, Emily A, Van Deerlin, Vivianna M, Levine, Matthew, Reddy, K. Rajender, Bloom, Roy D, Nazarian, Susanna M, Sawinski, Deirdre, Porrett, Paige, Naji, Ali, Hasz, Richard, Suplee, Lawrence, Trofe-Clark, Jennifer, Sicilia, Anna, McCauley, Maureen, Farooqi, Midhat, Gentile, Caren, Smith, Jennifer, Reese, Peter P

“…An open-label pilot trial involving 10 patients shows that hepatitis C virus genotype 1–infected kidneys transplanted into HCV-negative recipients, followed by…”
Get full text

Following the Flow: Changes in Organ Preservation Methods Require Changes in Our Data Collection by Sonnenberg, Elizabeth M, Abu-Gazala, Samir, Bittermann, Therese, Abt, Peter L

Get full text

Invited Response to Letter to the Editor by Callaghan et al, "Following the Flow: Changes in Organ Preservation Methods Require Changes in Our Data Collection" by Sonnenberg, Elizabeth M, Abu-Gazala, Samir, Bittermann, Therese, Abt, Peter L

Get full text

Have CFTR modulators changed the need for liver and lung transplantation among patients with cystic fibrosis? An analysis of the UNOS database by Mendizabal, Manuel, Cywes, Claire, Muñoz, Nicolas, Banker, Amay, Bermudez, Christian, Hadjiliadis, Denis, Abt, Peter L.

Get full text

Differences in Early Immunosuppressive Therapy Among Liver Retransplantation Recipients in a National Cohort by Mezochow, Alyssa K., Abt, Peter L., Bittermann, Therese

“…BACKGROUND:There is no unified consensus as to the preferred immunosuppression (IS) strategy following liver retransplantation (reLT). METHODS:This was a…”
Get full text

The role of exception points in outcomes of patients with fibrocystic liver-kidney disease: Implications for the National Liver Review Board by Rosenthal, Benjamin E, Abt, Peter L, Reddy, K Rajender, Bittermann, Therese

Get full text

Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group Trial by Reese, Peter P, Abt, Peter L, Blumberg, Emily A, Van Deerlin, Vivianna M, Bloom, Roy D, Potluri, Vishnu S, Levine, Matthew, Porrett, Paige, Sawinski, Deirdre, Nazarian, Susanna M, Naji, Ali, Hasz, Richard, Suplee, Lawrence, Trofe-Clark, Jennifer, Sicilia, Anna, McCauley, Maureen, Gentile, Caren, Smith, Jennifer, Niknam, Bijan A, Bleicher, Melissa, Reddy, K Rajender, Goldberg, David S

“…Organs from hepatitis C virus (HCV)-infected deceased donors are often discarded. Preliminary data from 2 small trials, including THINKER-1 (Transplanting…”
Get full text

Trends among kidney transplant candidates in the United States: Sifting through the tea leaves by Gupta, Meera, Abt, Peter L.

“…Schold and colleagues (page 414) examined changes in the prognosis for adult kidney transplant candidates placed on the kidney waiting list from 2001–2015 that…”
Get full text

New Solutions to Reduce Discard of Kidneys Donated for Transplantation by Reese, Peter P, Harhay, Meera N, Abt, Peter L, Levine, Matthew H, Halpern, Scott D

“…Kidney transplantation is a cost-saving treatment that extends the lives of patients with ESRD. Unfortunately, the kidney transplant waiting list has ballooned…”
Get full text

The effectiveness and safety of antibody induction immunosuppression in a large cohort of United States pediatric liver transplant recipients by Wood, Phoebe, Huang, Yuan-Shung, Sanchez, Lucia, Kitt, Eimear, Abt, Peter L., Bittermann, Therese

“…Data on the potential benefits and risks of induction therapy in pediatric liver transplantation (LT) are limited. This was a retrospective cohort study of…”
Get full text